Form D · Biotechnology
Scorpius Holdings, Inc.
Morrisville, NC · CIK 0001476963
Offering snapshot reported Feb 18, 2025 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 12, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 18, 2025 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Feb 12, 2025 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Dec 11, 2024 | Initial | $13,388,889 | No comparison | 2 | SEC filing |
| May 11, 2017 | Initial | $500,000 | No comparison | 45 | SEC filing |
| Apr 9, 2013 | Initial | $5,050,050 | No comparison | 20 | SEC filing |
| Dec 29, 2011 | Initial | $2,829,243 | No comparison | 3 | SEC filing |
| Nov 18, 2009 | Initial | $249,750 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538530
Promissory Note
Source: Form D, filed Feb 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Marc Belsky | Director |
| Vadim Deyev | Executive |
| Jennifer Lynn Harris | Executive |
| Jeffrey Hutchins | Executive |
| Scott Katzman | Director |
| Michael Kharitonov | Director |
| John Monahan | Director |
| William Ostrander | Executive |
| John Prendergast | Director |
| Ann Rosar | Executive |
| Sandra Leta Silberman | Executive |
| Edward Smith | Director |
| Edward Byron Smith, Iii | Director |
| Taffy Williams | Executive |
| Jeff Wolf | Director, Executive |
| Jeffrey Wolf | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
627 Davis Drive Suite 300
Morrisville, NC, 27560
Morrisville, NC, 27560